PRRT2 and myotonic dystrophy type 1: Their altered activity in DM1 cells also correlate with changes in signaling pathways of various protein kinases including cyclin-dependent kinases (CDKs), glycogen synthase kinase 3β (GSK3β), AKT, and protein kinase C (PKC) (8, 15, 16).